α7烟碱样乙酰胆碱受体激动剂后处理对高胆固醇血症大鼠在体心肌缺血/再灌注损伤的影响

摘要
图/表
参考文献
相关文章 (10)

全文: PDF (629 KB)
输出: BibTeX | EndNote (RIS)

摘要目的评价α7烟碱样乙酰胆碱受体(α7 nicotinic acetylcholine receptor,α7nAChR)激动剂后处理对高胆固醇血症大鼠心肌保护作用的影响。方法采用含2%胆固醇和0.5%胆盐的饲料喂养大鼠30只,时间为8周,以诱发高胆固醇血症。采用随机数字表法将高胆固醇血症和正常大鼠分为对照组(HC组和NC组)、缺血/再灌注损伤组(HI组和NI组)和PNU282987后处理组(HPNU组和NPNU组),每组5只。检测血清总胆固醇(TC)、低密度脂蛋白(LDL)、肌酸激酶同工酶(CK-MB)、肌钙蛋白I(cTnI),肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平;采用伊文氏蓝和氯化三苯基四氮唑 (TTC)双重染色法测定心肌梗死面积。结果与NC组比较,HC组TC和LDL明显升高(P<0.05);与NI组比较, NPNU组血清CKMB和cTnI水平明显降低,血清TNF-α和IL-6水平明显降低,心肌梗死面积明显缩小(P<0.05)。与HI组比较,HPNU组血清CKMB、cTnI、TNF-α和IL-6水平、心肌梗死面积比较差异均无统计学意义。结论高胆固醇血症可明显加重心肌缺血/再灌注损伤,并消除α7nAChR激动剂后处理的心肌保护作用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	温超
	薛富善
	王玉慧
	金锦花

关键词 ：缺血/再灌注损伤, 高胆固醇血症, 心肌保护

Abstract：Objective To evaluate the effect of postconditioning with α7 nicotinic acetylcholine receptor (α7nAChR) agonist on myocardial protection in hypercholesterolemic rats.Methods A hypercholesterolemic model of rats was induced by means of a eight-week diet containing 2% cholesterol and 0.5% bile salts. Hypercholesterolemic and normal rats were randomly divided into three groups respectively (n=5): control group (group HC and NC), ischemia/reperfusion injury group (group HI and NI), and PNU282987 postconditioning group (group HPNU and NPNU). Serum levels of total cholesterol (TC), low-density lipoprotein (LDL), creatine kinase MB (CK-MB), cardiac troponin I (cTnI), tumor necrosis factor (TNF) -α and interleukin (IL) -6 were assayed. The size of myocardial infarction was determined by Evans blue and triphenyltetrazolium chloride (TTC) staining.Results Compared with group NC, levels of TC and LDL were elevated significantly in group HC (P<0.05). Compared with group NI, serum levels of CKMB, cTnI, TNF-α, IL-6, and myocardial infarct size were decreased significantly in group NPNU (P<0.05). No significant difference was found between group HI and group HPNU (P>0.05).Conclusions Hypercholesterolemia can aggravate myocardial ischemia/reperfusion injury and eliminate the myocardial protective effect of α7nAChR agonist postconditioning against myocardial ischemia/reperfusion injury.

Key words： ischemia/reperfusion injury hypercholesterolemia cardioprotection

收稿日期: 2021-06-19

ZTFLH:

R541.4

基金资助:国家自然科学基金(81470019);中国医学科学院整形外科医院院所青年创新基金(Q2017002)

通讯作者: 薛富善,E-mail:xuefushan@aliyun.com

作者简介: 温超,硕士,主治医师。

引用本文:

温超, 薛富善, 王玉慧, 金锦花. α7烟碱样乙酰胆碱受体激动剂后处理对高胆固醇血症大鼠在体心肌缺血/再灌注损伤的影响[J]. 武警医学, 2021, 32(8): 698-701. WEN Chao, XUE Fushan, WANG Yuhui, JIN Jinhua. Effect of postconditioning with α7 nicotinic acetylcholine receptor agonist on myocardial ischemia/reperfusion injury in rats with hypercholesterolemia. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(8): 698-701.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2021/V32/I8/698

[1]	Heusch G, Gersh B J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge[J]. Eur Heart J,2017,38(11):774-784.
[2]	Xiong J, Yuan Y J, Xue F S, et al. Postconditioning with α7nAChR agonist attenuates systemic inflammatory response to myocardial ischemia-reperfusion injury in rats[J]. Inflammation, 2012, 35 (4):1357-1364.
[3]	Andreadou I, Iliodromitis E K, Lazou A, et al. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning[J]. Br J Pharmacol, 2017,174(12):1555-1569.
[4]	Yang J T, Wang J, Zhou X R, et al. Luteolin alleviates cardiac ischemia/reperfusion injury in the hypercholesterolemic rat via activating Akt/Nrf2 signaling[J]. Naunyn Schmiedebergs Arch Pharmacol, 2018,391(7):719-728.
[5]	Chan K W, Ismail M, Mohd E N, et al. Defatted Kenaf (Hibiscus cannabinus L.) seed Meal and its phenolic-saponin-Rich Extract Protect Hypercholesterolemic Rats against oxidative stress and systemic Inflammation via Transcriptional Modulation of Hepatic Antioxidant Genes[J]. Oxid Med Cell Longev, 2018,2018:6742571.
[6]	Li H X, Cui X L, Xue F S, et al. Inhibition of glycogen synthase kinase-3β is involved in cardioprotection by α7nAChR agonist and limb remote ischemic postconditionings[J]. Biosci Rep, 2018,38(5): BSR20181315.
[7]	Liu Y Y, Sun C, Xue F S, et al. Effect of autophagy Inhibition on the protection of ischemia preconditioning against Myocardial Ischemia/Reperfusion Injury in Diabetic Rats[J]. Chin Med J (Engl),2018,131(14):1702-1709.
[8]	Blay R M, Adjenti S K, Adutwum-Ofosu K K, et al. Natural cocoa inhibits maternal hypercholesterolaemia-induced atherogenesis in rabbit pups[J]. Cardiovasc J Afr,2019,30(4):208-215.
[9]	Lin Z J, Zhang B, Liu X Q, et al. Abdominal fat accumulation with hyperuricemia and hypercholesterolemia quail model induced by high fat diet. Chin Med Sci J[J]. 2009, 24(3):191-194.
[10]	Chandra A, Sharma K, Pratap K, et al. Inhibition of microRNA-128-3p attenuates hypercholesterolemia in mouse model[J]. Life Sci,2021,264:118633.
[11]	Low LD, Lu L, Chan CY, et al. IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease[J]. Clin Sci (Lond),2020,134(2):225-237.
[12]	刘悦, 彭云水, 刘雅,等. PI3K-Akt-eNOS信号转导通路在七氟醚后处理减轻大鼠心肌缺血再灌注损伤中的作用[J]. 中华麻醉学杂志 2012, 32(3): 371-374.
[13]	Low LD, Lu L, Chan C Y, et al. IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease[J]. Clin Sci (Lond) ,2020, 134(2):225-237.
[14]	Zhu J, Wang Y F, Chai X M, et al. Exogenous NADPH ameliorates myocardial ischemia-reperfusion injury in rats through activating AMPK/mTOR pathway[J]. Acta Pharmacol Sin, 2020,41(4):535-545.
[15]	Sharma N K, Mahadevan N, Balakumar P. Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors[J]. Cardiovasc Toxicol, 2013,13(1):22-32.
[16]	崔昕龙, 王世玉, 薛富善, 等. α7nAChR激动剂后处理及其联合肢体远隔缺血后处理抑制大鼠心肌缺血再灌注时炎症反应的机制:与糖原合成酶激酶-3β的关系[J]. 中华麻醉学杂志, 2018,38(1):78-82.
[17]	Mazo T, D'Annunzio V, Donato M, et al. Dyslipidemia in Ischemia/Reperfusion Injury[J]. Adv Exp Med Biol, 2019,1127:117-130.
[18]	Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications[J]. Am Heart J, 1999,138: S69-75.
[19]	Steffens S, Montecucco F, Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury[J]. Thromb Haemost, 2009,102(2):240-247.
[20]	Wu Y, Liu H, Wang X. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury[J]. Life Sci, 2021,264:118628.